Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 1992Journal of VirologyOpen Access

Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity

View Full Paper
Ask AI
Bookmark
Share

Authors

MHM L HammarskjöldUniversity of VirginiaMSM C SimurdaUniversity at Buffalo, State University of New York

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hammarskjöld et al. (1992) studied this question.

synapsesocial.com/papers/6a1a7ad07ff99bba0645bd50https://doi.org/10.1128/jvi.66.11.6496-6501.1992
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evidence for molecular subtypes of HIV-associated lymphoma1991 · 97 citations
  2. 2Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization, and cytoskeletal association1991 · 88 citations
  3. 3Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity1988 · 393 citations
  4. 4Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD231990 · 575 citations
  5. 5Functionally Distinct NF-κB Binding Sites in the Immunoglobulin κ and IL-2 Receptor α Chain Genes1989 · 195 citations